Imatinib Unknown Status Phase 2 Trials for Nephrogenic Systemic Fibrosis Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00677092Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis